Urinary Retention
📧 Sign up to get email alerts when something new happens for Urinary Retention.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-11-02FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Eugia US LLC)
FDA approved the original application (ANDA 213244) for Neostigmine methylsulfate by Eugia US LLC, authorizing its generic entry and labelin…
-
FDA approval · 2015-12-28FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Civica, Inc.)
FDA approved Civica, Inc.'s original application for Neostigmine Methylsulfate, a generic version of the drug.
-
FDA approval · 2010-05-04FDA Approved: BETHANECHOL CHLORIDE — Original Application (Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.)
FDA approved Bethanechol chloride under an original generic application from Heritage Pharma Labs (Avet Pharmaceuticals Labs Inc.).
-
FDA approval · 2007-11-21FDA Approved: BETHANECHOL CHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal Pharmaceuticals of New York LLC's Bethanechol chloride as an original generic application (ANDA). It is indicated for no…
-
FDA approval · 2007-10-26FDA Approved: BETHANECHOL CHLORIDE — Original Application (Chartwell RX, LLC)
FDA approved Bethanechol chloride under an Original Application from Chartwell RX, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.